| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.9B | $3.6B | $3.3B | $3.0B | $2.8B | $2.5B | $2.8B | $2.7B |
| Cost of Revenue | $2.5B | $2.4B | $2.2B | $2.1B | $1.9B | $1.7B | $1.9B | $1.9B |
| Gross Profit | $1.4B | $1.2B | $1.1B | $0.9B | $0.9B | $0.8B | $0.9B | $0.9B |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.7B | $0.7B | $0.5B | $0.5B | $0.5B | $0.2B | $0.4B | $0.4B |
| Net Income | $0.5B | $0.5B | $0.4B | $0.4B | $0.3B | $0.1B | $0.3B | $0.3B |
| EPS (Basic) | $6.15 | $6.34 | $4.99 | $4.40 | $3.68 | $0.84 | $3.71 | $3.81 |
| EPS (Diluted) | $6.11 | $6.30 | $4.96 | $4.38 | $3.66 | $0.83 | $3.67 | $3.76 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.3B | $4.7B | $3.9B | $3.8B | $3.6B | $4.3B | $4.1B | $3.8B |
| Current Assets | $3.4B | $1.9B | $1.9B | $1.8B | $1.7B | $1.9B | $1.7B | $1.6B |
| Cash & Equivalents | $1.7B | $0.4B | $0.5B | $0.6B | $0.6B | $0.9B | $0.6B | $0.6B |
| Total Liabilities | $2.2B | $1.9B | $1.4B | $1.5B | $1.3B | $2.1B | $2.0B | $2.0B |
| Current Liabilities | $1.3B | $1.3B | $1.0B | $1.2B | $0.9B | $0.9B | $0.8B | $0.9B |
| Stockholders' Equity | $4.1B | $2.8B | $2.5B | $2.2B | $2.2B | $2.1B | $2.1B | $1.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | — | — | — | — | — | — | — | — |
| Investing Cash Flow | $-0.1B | $-0.8B | $-0.2B | $-0.3B | $-0.1B | $-0.1B | $-0.2B | — |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.7B | $0.2B | $-0.4B | $-0.1B | $-0.1B | $-0.2B | $-0.1B | — |